Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors - Odessa American -BoardProspects

Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors

Odessa American Oct 8 2020 BoardMoves

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the appointment of Mark Litton, PhD, MBA, Chief Operating Officer of Athira Pharma (NASDAQ: ATHA), to the company's Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors also published in Odessa American
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors also published in Odessa American
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
- Board of directors
- Board
- Nasdaq
- MBA
- Mark Litton